WHO Immunization Implementation Guide
0.2.0 - ci-build

WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/ and changes regularly. See the Directory of published versions

ValueSet: IMMZ.D.Observation ValueSet for Sex

Official URL: http://smart.who.int/immunizations/ValueSet/IMMZ.D.Observation Version: 0.2.0
Active as of 2025-08-08 Computable Name: IMMZ_D_Observation

ValueSet for Observation codes for IMMZ.D

References

Logical Definition (CLD)

  • Include these codes as defined in http://smart.who.int/immunizations/CodeSystem/IMMZ.D
    CodeDisplayDefinition
    DE263Birth doseIndicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen
    DE203Completed the primary vaccination seriesIndicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen
    DE257Completed the booster seriesIndicates if the client has completed the booster series of a product/antigen
    DE242Date when primary vaccination series was completedThe date when the client completed the primary vaccination series (per product/antigen)
    DE204HIV statusThe current HIV status of the client
    DE208Preterm birthThe infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks
    DE209ImmunocompromisedThe client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases
    DE210Currently on ARTThe client is currently receiving antiretroviral therapy (ART)
    DE243Type of TB infection test performedThe type of tuberculosis (TB) infection test performed
    DE246TB infection test resultRecords the result of the TB infection test
    DE249Immunologically stableThe client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines
    DE250Clinically wellThe client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging
    DE211Birth weight in gramsRepresents the client's birth weight value measures in grams
    DE215ART start dateThe date on which the client started or restarted ART
    DE251High risk of pneumococcal infectionThe client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)
    DE236Age in months when client received first meningococcal doseThe age in months when client received their first meningococcal dose
    DE240VNA levelVaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV)
    DE253Risk of occupational exposure to rabies virusProfessional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies
    DE241Dengue serostatusIndicates the result of a serological test determining whether the client has antibodies against the dengue virus
    DE201Contact dateThe date and time of the client's contact
    DE202ANC contact numberThe antenatal care (ANC) contact or visit number

 

Expansion

This value set expansion contains 21 concepts.

CodeSystemDisplayDefinition
  DE263http://smart.who.int/immunizations/CodeSystem/IMMZ.DBirth doseIndicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen
  DE203http://smart.who.int/immunizations/CodeSystem/IMMZ.DCompleted the primary vaccination seriesIndicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen
  DE257http://smart.who.int/immunizations/CodeSystem/IMMZ.DCompleted the booster seriesIndicates if the client has completed the booster series of a product/antigen
  DE242http://smart.who.int/immunizations/CodeSystem/IMMZ.DDate when primary vaccination series was completedThe date when the client completed the primary vaccination series (per product/antigen)
  DE204http://smart.who.int/immunizations/CodeSystem/IMMZ.DHIV statusThe current HIV status of the client
  DE208http://smart.who.int/immunizations/CodeSystem/IMMZ.DPreterm birthThe infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks
  DE209http://smart.who.int/immunizations/CodeSystem/IMMZ.DImmunocompromisedThe client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases
  DE210http://smart.who.int/immunizations/CodeSystem/IMMZ.DCurrently on ARTThe client is currently receiving antiretroviral therapy (ART)
  DE243http://smart.who.int/immunizations/CodeSystem/IMMZ.DType of TB infection test performedThe type of tuberculosis (TB) infection test performed
  DE246http://smart.who.int/immunizations/CodeSystem/IMMZ.DTB infection test resultRecords the result of the TB infection test
  DE249http://smart.who.int/immunizations/CodeSystem/IMMZ.DImmunologically stableThe client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines
  DE250http://smart.who.int/immunizations/CodeSystem/IMMZ.DClinically wellThe client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging
  DE211http://smart.who.int/immunizations/CodeSystem/IMMZ.DBirth weight in gramsRepresents the client's birth weight value measures in grams
  DE215http://smart.who.int/immunizations/CodeSystem/IMMZ.DART start dateThe date on which the client started or restarted ART
  DE251http://smart.who.int/immunizations/CodeSystem/IMMZ.DHigh risk of pneumococcal infectionThe client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)
  DE236http://smart.who.int/immunizations/CodeSystem/IMMZ.DAge in months when client received first meningococcal doseThe age in months when client received their first meningococcal dose
  DE240http://smart.who.int/immunizations/CodeSystem/IMMZ.DVNA levelVaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV)
  DE253http://smart.who.int/immunizations/CodeSystem/IMMZ.DRisk of occupational exposure to rabies virusProfessional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies
  DE241http://smart.who.int/immunizations/CodeSystem/IMMZ.DDengue serostatusIndicates the result of a serological test determining whether the client has antibodies against the dengue virus
  DE201http://smart.who.int/immunizations/CodeSystem/IMMZ.DContact dateThe date and time of the client's contact
  DE202http://smart.who.int/immunizations/CodeSystem/IMMZ.DANC contact numberThe antenatal care (ANC) contact or visit number

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code